The division has very active bench, clinical and translational research activities with six clinical faculty, two tenure track basic science faculty and over 30 additional research assistants, students and support personal. The division had over two million dollars in direct research funding in 2009.
Friedhelm Hildebrandt, an Investigator of the Howard Hughes Medical Institute, leads a world renowned research program with faculty members Dr Edgar Otto PhD and Toby Hurd PhD. This laboratory investigates monogenic kidney diseases (nephrotic syndrome, urogenitial malformations, and renal cystic "ciliopathies"). This 15-member team includes six post-docs and four students.
Debbie Gipson is a clinical researcher with expertise in clinical trials and quality of life measures in chronic disease. Much of her research focuses on interventions in Nephrotic Syndrome and measurements of patient reported outcomes in Chronic Kidney Disease and Dialysis.
Neal Blatt is a junior faculty member whose research interest is in the impact of extracorporal circuits on immune function. He is specifically looking at the impact of hemodialysis circuits on lymphocyte function.
David Kershaw is currently enrolling patients with Chronic Kidney Disease in a longitudinal clinical phenotyping biobank (CPROBE), and has a longstanding interest in podocyte biology.